Search Results - "Laird, Amanda"

Association of Medicaid expansion of the Affordable Care Act with operations for benign endocrine surgical disease by Manzella, Alexander, Laird, Amanda M., Beninato, Toni

“…•Background: The Affordable Care Act's Medicaid expansion increased insurance coverage and access to care for endocrine cancers, though impact on benign…”
Get full text

Effects of the COVID-19 pandemic on endocrine operations in the United States by Manzella, Alexander, Kravchenko, Timothy, Kheng, Marin, Chao, Joshua, Laird, Amanda M., Pitt, Henry A., Beninato, Toni

“…The COVID-19 pandemic disrupted the United States (US) healthcare system. Endocrine operations are predominantly elective and were likely affected. Therefore,…”
Get full text

Association of Medicaid expansion with access to thyroidectomy for benign disease at high-volume centers by Manzella, Alexander, Kheng, Marin, Chao, Joshua, Laird, Amanda M., Beninato, Toni

“…Insurance-based disparities in access to thyroidectomy are well established. Patients undergoing thyroidectomy by high-volume surgeons have fewer complications…”
Get full text

Is Less More? Adoption of Treatment Guidelines for Low-Risk Papillary Thyroid Cancer by Beninato, Toni, Laird, Amanda M.

Get full text

Total Thyroidectomy and Low-Risk Thyroid Cancer: Are We Treating the Surgeon or Patient? by Laird, Amanda M., Beninato, Toni

Get full text

Shedding new light on old complications: CESQIP and understanding post-thyroidectomy outcomes by Beninato, Toni, Laird, Amanda M.

“…NSQIP provided thyroid surgeons with data on 30-day complications common to all surgical procedures such as urinary tract infections (UTI), surgical site…”
Get full text

The association of Medicaid expansion and parathyroidectomy for benign disease: Insurance status remains an important factor in access to high-volume centers by Kheng, Marin, Ko, Tomohiro, Manzella, Alexander, Chao, Joshua C., Laird, Amanda M., Beninato, Toni

“…Medicaid expansion has been associated with improved access to surgical care at high-volume centers. Its impact on parathyroidectomy, however, is unclear. We…”
Get full text

Reoperation Rates After Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study by Kheng, Marin, Manzella, Alexander, Chao, Joshua C, Laird, Amanda M, Beninato, Toni

“…The 2015 American Thyroid Association (ATA) guidelines recommended thyroid lobectomy (TL) as an alternative to total thyroidectomy (TT) for the surgical…”
Get more information

Malpractice litigation after thyroid surgery: What factors favor surgeons? by Chao, Joshua C, Kheng, Marin, Manzella, Alexander, Beninato, Toni, Laird, Amanda M

“…Litigation impacts physicians financially, reputationally, and professionally. Although thyroid surgery has favorable patient outcomes, litigation persists. We…”
Get full text

Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors by Rosenberg, Alex M., BA, Friedmann, Patricia, MS, Del Rivero, Jaydira, MD, Libutti, Steven K., MD, Laird, Amanda M., MD

“…Background Sporadic, nonfunctional pancreatic neuroendocrine tumors (NF-PNETs) are diagnosed with increasing frequency. We compared the risk of tumor growth,…”
Get full text

Radiology report language positively influences adrenal incidentaloma guideline adherence by Watari, Jessica, Vekaria, Shivani, Lin, Yong, Patel, Manank, Kim, Hyon, Kang, Francis, Lubitz, Sara, Beninato, Toni, Laird, Amanda M.

“…Adrenal incidentalomas are common radiographic findings. Guidelines recommend biochemical and radiographic surveillance of adrenal incidentalomas. We…”
Get full text

Which Ultrasound Characteristics Predict Lymphatic Spread of Papillary Thyroid Cancer? by Kravchenko, Timothy, Chen, Vivian, Hsu, Daniel, Manzella, Alexander, Kheng, Marin, Laird, Amanda M., Simon, Mitchell, Trooskin, Stanley, Beninato, Toni

“…The 2015 American Thyroid Association guidelines recommend lymph node mapping US in patients with definitive cytological evidence of thyroid cancer. Suspicious…”
Get full text

Which Localizing Strategy is the Most Cost-Effective in Reoperative Primary Hyperparathyroidism? by Gazivoda, Victor, Prioli, Katherine M., Li, Albert C., Pizzi, Laura, Laird, Amanda M., Beninato, Toni

“…2%-10% of patients with primary hyperparathyroidism (PHPT) who undergo parathyroidectomy develop persistent/recurrent disease. The aim of this study was to…”
Get full text

Association of Implementation of Operating Room-Based Parathyroid Hormone Testing with Operative Time and Cost by Xie, Steven, Kuriakose, Jonathan, Beninato, Toni, Carayannopoulos, Mary, Trooskin, Stanley Z, Libutti, Steven K, Laird, Amanda M

“…Intraoperative parathyroid hormone (IOPTH) testing facilitates focused parathyroidectomy to establish biochemical cure but may be time-consuming. A dedicated…”
Get full text

Impact of the COVID-19 pandemic on the practice of endocrine surgery by Beninato, Toni, Laird, Amanda M., Graves, Claire E., Drake, F. Thurston, Alhefdhi, Amal, Lee, James A., Kuo, Jennifer H., Grubbs, Elizabeth G., Wang, Tracy S., Pasieka, Janice L., Lubitz, Carrie C.

“…This study investigates the impact of the COVID-19 pandemic on endocrine surgeons. A survey on the professional, educational, and clinical impact was sent to…”
Get full text

Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism by Laird, Amanda M., MD, Libutti, Steven K., MD

“…Primary hyperparathyroidism is a disease that is caused by excess parathyroid hormone (PTH) secretion from 1 or more of the parathyroid glands. Surgery is the…”
Get full text

Management of Other Gastric and Duodenal Neuroendocrine Tumors by Laird, Amanda M., Libutti, Steven K.

“…Gastric and duodenal neuroendocrine tumors (NETs) are increasing in incidence as a result of increased detection and awareness of neuroendocrine tumors as…”
Get full text

Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study by Tumati, Abhinay, Marshall, Teagan E., Greenspun, Benjamin, Chen, Zhengming, Azar, Sara Abou, Keutgen, Xavier M., Laird, Amanda M., Beninato, Toni, Zarnegar, Rasa, Fahey, Thomas J., Finnerty, Brendan M.

“…Integrating microRNA markers with next-generation sequencing panels may enhance risk assessment of cytologically indeterminate thyroid nodules. The…”
Get full text

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study by Tumati, Abhinay, Egan, Caitlin E, Lee-Saxton, Yeon J, Marshall, Teagan E, Lee, Joyce, Jain, Kavita, Heymann, Jonas J, Gokozan, Hamza, Azar, Sara Abou, Schwarz, Jason, Keutgen, Xavier M, Laird, Amanda M, Beninato, Toni, Zarnegar, Rasa, Fahey, 3rd, Thomas J, Finnerty, Brendan M

“…Molecular testing guides the management of cytologically indeterminate thyroid nodules. We evaluated the real-world clinical benefit of a commercially…”
Get full text

Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma by Thiesmeyer, Jessica W., Limberg, Jessica, Ullmann, Timothy M., Greenberg, Jacques A., Egan, Caitlin E., Moore, Maureen, Finnerty, Brendan M., Laird, Amanda M., Zarnegar, Rasa, Fahey, Thomas J., Beninato, Toni

“…We aimed to characterize the association between differentiated thyroid cancer (DTC) patient insurance status and appropriateness of therapy (AOT) regarding…”
Get full text